Growth Metrics

Bionano Genomics (BNGO) Gross Profit (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Gross Profit for 9 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 57.54% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, up 165.33% year-over-year, with the annual reading at $13.2 million for FY2025, 3369.74% up from the prior year.
  • Gross Profit hit $3.4 million in Q4 2025 for Bionano Genomics, up from $3.4 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2024 to a low of -$8.4 million in Q3 2024.
  • Historically, Gross Profit has averaged $1.9 million across 5 years, with a median of $2.2 million in 2023.
  • Biggest five-year swings in Gross Profit: soared 655.23% in 2022 and later plummeted 407.24% in 2024.
  • Year by year, Gross Profit stood at $239000.0 in 2021, then skyrocketed by 655.23% to $1.8 million in 2022, then soared by 35.07% to $2.4 million in 2023, then surged by 228.38% to $8.0 million in 2024, then plummeted by 57.54% to $3.4 million in 2025.
  • Business Quant data shows Gross Profit for BNGO at $3.4 million in Q4 2025, $3.4 million in Q3 2025, and $3.5 million in Q2 2025.